Author results

3HHA
  • Download 3hha
  • View 3hha
Molmil generated image of 3hha
CRYSTAL STRUCTURE OF CATHEPSIN L IN COMPLEX WITH AZ12878478
Descriptor:Cathepsin L1, Nalpha-[(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)carbonyl]-N-[(2Z)-2-iminoethyl]-3-methyl-L-phenylalaninamide, TETRAETHYLENE GLYCOL, ...
Authors:Asaad, N., Bethel, P.A., Coulson, M.D., Dawson, J., Ford, S.J., Gerhardt, S., Grist, M., Hamlin, G.A., James, M.J., Jones, E.V., Karoutchi, G.I., Kenny, P.W., Morley, A.D., Oldham, K., Rankine, N., Ryan, D., Wells, S.L., Wood, L., Augustin, M., Krapp, S., Simader, H., Steinbacher, S.
Deposit date:2009-05-15
Release date:2009-06-23
Last modified:2018-05-30
Method:X-RAY DIFFRACTION (1.27 Å)
Cite:Dipeptidyl nitrile inhibitors of Cathepsin L.
Bioorg.Med.Chem.Lett., 19, 2009
3HWN
  • Download 3hwn
  • View 3hwn
Molmil generated image of 3hwn
CATHEPSIN L WITH AZ13010160
Descriptor:Cathepsin L1, Nalpha-[(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)carbonyl]-N-[(2E)-2-iminoethyl]-3-{5-[(Z)-iminomethyl]-1,3,4-oxadiazol-2-yl}-L-phenylalaninamide
Authors:Kenny, P., Morley, A.
Deposit date:2009-06-18
Release date:2009-09-15
Last modified:2017-11-01
Method:X-RAY DIFFRACTION (2.33 Å)
Cite:Design of selective Cathepsin inhibitors
Bioorg.Med.Chem.Lett., 19, 2009
4LI5
  • Download 4li5
  • View 4li5
Molmil generated image of 4li5
EGFR-K IN COMPLEX WITH N-[3-[[5-CHLORO-4-(1H-INDOL-3-YL)PYRIMIDIN-2-YL]AMINO]-4-METHOXY-PHENYL] PROP-2-ENAMIDE
Descriptor:Epidermal growth factor receptor, N-(3-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-4-methoxyphenyl)propanamide, SODIUM ION
Authors:Debreczeni, J.E., Seiffert, G.B., Kiefersauer, R., Augustin, M., Nagel, S., Ward, R., Anderton, M., Ashton, S., Bethel, P., Box, M., Butterworth, S., Colclough, N., Chroley, C., Chuaqui, C., Cross, D., Eberlein, C., Finlay, R., Hill, G., Grist, M., Klinowska, T., Lane, C., Martin, S., Orme, J., Smith, P., Wang, F., Waring, M.
Deposit date:2013-07-02
Release date:2013-08-28
Last modified:2013-09-25
Method:X-RAY DIFFRACTION (2.64 Å)
Cite:Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR).
J.Med.Chem., 56, 2013